tirzepatide and triglycerides Systemic effects of dually activating GLP-1 GIP Tirzepatide | OneTwenty Meds

They do not address the immune dysregulation that drives psoriasis

V., Dave S

Important safety considerations include: Cardiovascular history : Patients with established cardiovascular disease require careful assessment, though recent evidence suggests GLP-1 receptor agonists may offer cardiovascular benefits Medication interactions : No clinically significant interactions are expected between GLP-1 receptor agonists and statins or other lipid-lowering medications, though delayed gastric emptying could theoretically affect absorption of oral medications Pancreatitis risk : Whilst rare, acute pancreatitis has been reported with GLP-1 receptor agonists

10.1016/S2215-0366(17)30015-9 63